In addition to being affordable, you might also think of the cost savings youll reap when you reduce your risk of expensive chronic conditions associated with obesity, including diabetes, heart disease, and some cancers
The study showed that patients who switched to the pill from injectable Wegovy regained an average of 0.9 kilograms, or 2 pounds, while those who switched from Zepbound, which produced greater weight loss, regained an average of 5 kilograms, or 11 pounds
Lower Risk of Hypoglycemia: Compared to some other diabetes medications, semaglutide carries a reduced risk of causing hypoglycemia, ensuring safer blood sugar management
Stimulation of Natural GLP-1 : Supergut underlines the importance of prebiotic fiber that helps consumers to naturally increase their GLP-1 levels
However, side effects and high costs are some reasons people stop using Wegovy